This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (67)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A New Genetic Mechanism for Acute Leukemia

Steven A. Schichman, MD, PhD; Eli Canaani, PhD; Carlo M. Croce, MD

JAMA. 1995;273(7):571-576.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

LEUKEMIA is a clonal malignancy of blood cells that usually involves the myeloid or lymphoid lineages. The origin of leukemia, like other forms of cancer, lies in gene defects that alter the normal programs of cellular differentiation, proliferation, or apoptosis. Using chromosomal rearrangements as a guidepost to the location of genes involved in hematologic malignancy, researchers have identified and molecularly characterized many leukemia genes during the last decade.¹ These studies have revealed some common genetic mechanisms for leukemogenesis, provided molecular tools for leukemia diagnosis and monitoring, and identified potential targets for a new generation of leukemia therapies.

One of the most significant of these genetic findings involves the ALL1 gene, which participates in acute leukemias in 5% to 10% of children and adults. Like other leukemia genes, ALL1 was discovered by its association with well-characterized chromosomal rearrangements. However, we have recently found that the ALL1 gene also participates in . . . [Full Text PDF of this Article]

Author Affiliations
From the Jefferson Cancer Institute, Jefferson Cancer Center, and Department of Microbiology and Immunology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pa (Drs Schichman and Croce), and the Department of Chemical Immunology, The Weizmann Institute, Rehovot, Israel (Dr Canaani).

Footnotes
Reprint requests to Jefferson Cancer Institute, Thomas Jefferson University, Bluemle Life Sciences Bldg, Room 1035, 233 S 10th St, Philadelphia, PA 19107-5799 (Dr Schichman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?